No, it was mentioned in the first study and not Data Confirmation. Bruh, if you are questioning the technology but it seem like you just invested for the COVID-19 screening and not ResAppDx since you seem to know very little about ResAppDx then it's time to sell or do more due diligence on ResAppDx which is RAP's core product.
- Forums
- ASX - By Stock
- RAP
- Response No-vote letter update
Response No-vote letter update, page-42
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAP (ASX) to my watchlist
|
|||||
Last
20.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $176.2M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
MND
Monadelphous inks $200M contract with Woodside to help build Pluto LNG – but will it make Scarborough cheaper?
IGO
IGO kicks off earn-in copper drilling on-site Encounter's Yeneena play as it adopts new identity
RAP (ASX) Chart |
Day chart unavailable